Showing results (2691-2700 of 3,978) with videos related to

Sort By:
Pageof 398
European Journal of Heart Failure|January 22, 2022
Dapagliflozin reduces uric acid concentration, an independent predictor of adverse outcomes in DAPA-HFKirsty McDowell, Paul Welsh, Kieran F Docherty, et al.
European Journal of Heart Failure|March 18, 2022
The effect of intravenous ferric carboxymaltose on right ventricular function - insights from the IRON-CRT trialPieter Martens, Matthias Dupont, Jeroen Dauw, et al.
European Journal of Heart Failure|April 27, 2022
Epicardial adipose tissue related to left atrial and ventricular function in heart failure with preserved versus reduced and mildly reduced ejection fractionXuanyi Jin, Chung-Lieh Hung, Wan Ting Tay, et al.
European Journal of Heart Failure|April 16, 2022
Quality of life assessed 6 months after hospitalisation for acute heart failure: an analysis from REPORT-HF (international REgistry to assess medical Practice with lOngitudinal obseRvation for Treatment of Heart Failure)Candace D McNaughton, Alex McConnachie, John G Cleland, et al.
European Journal of Heart Failure|September 8, 2018
Assessment of baroreflex sensitivity has no prognostic value in contemporary, optimally managed patients with mild-to-moderate heart failure with reduced ejection fraction: a retrospective analysis of 5-year survivalBartłomiej Paleczny, Martyna Olesińska-Mader, Agnieszka Siennicka, et al.
European Journal of Heart Failure|September 8, 2018
Activity and outcomes of a cardio-oncology service in the United Kingdom-a five-year experienceNilesh Pareek, Joaquim Cevallos, Pedro Moliner, et al.
European Journal of Heart Failure|June 27, 2018
Multi-ethnic comparisons of diabetes in heart failure with reduced ejection fraction: insights from the HF-ACTION trial and the ASIAN-HF registryLauren B Cooper, Jonathan Yap, Wan Ting Tay, et al.
European Journal of Heart Failure|May 23, 2019
Treatment of functional mitral regurgitation in chronic heart failure: can we get a 'proof of concept' from the MITRA-FR and COAPT trials?Michele Senni, Marianna Adamo, Marco Metra, et al.
European Journal of Heart Failure|June 21, 2019
Rationale and design of the EMPERIAL-Preserved and EMPERIAL-Reduced trials of empagliflozin in patients with chronic heart failureWilliam T Abraham, Piotr Ponikowski, Martina Brueckmann, et al.
European Journal of Heart Failure|June 21, 2019
Expert consensus document: Reporting checklist for quantification of pulmonary congestion by lung ultrasound in heart failureElke Platz, Pardeep S Jhund, Nicolas Girerd, et al.
Pageof 398